Skip navigation

Sitemap

Home Home Contact us Urdu Sitemap	Hepatitis C Info About Hepatitis C About hepatitis C What is a virus? The hepatitis C virus Symptoms of chronic infection with hepatitis C Risk Factors What are the risk factors? Understanding risk Drug use Blood and blood products Haemodialysis Hairdressers & barbers Household transmission (sharing razors and toothbrushes) Medical and dental procedures Mother to baby Needlestick injury Piercing Sexual contact Steroids Tattoos Vaccinations Just Diagnosed Just diagnosed? Could they have made a mistake? How did I get it? Is my partner and everyone around me now at risk? Telling people Other questions Stages of Hepatitis C Introduction Overview of the stages The acute phase The chronic phase Factors affecting progression Hepatitis C and HIV End stage liver disease Symptoms Testing Process Things to consider Reasons to get tested Asking for a test The Antibody test The PCR test Assessment of liver damage Where to get tested The Liver Anatomy and physiology Functions of the liver Location of the liver How it works Inside the liver How HCV affects the functions of the liver Compensated cirrhosis Steatosis (fatty liver) Liver cancer HCV and liver cancer Tests for liver cancer Treatment for liver cancer	Treatment Considering Treatment Considering treatment Choosing treatment Contraindications Preparing for treatment Treatment for people with cirrhosis Conventional Treatment Overview of conventional treatment Interferons and ribavirin Interactions with other drugs How to do treatment The Treatment Process Managing treatment Duration of treatment and ribavirin dosage Effectiveness Adherence Side effects Understanding tests Retreatment Maintenance therapy New Treatments Boceprevir (Victrelis) and Telaprevir (Incivo, Incivek) Telaprevir (Incivo, Incivek) Telaprevir Q & A Boceprevir (Victrelis®) Boceprevir Q & A Interactions with other drugs Potential New Drugs Potential new drugs introduction Drugs that target the virus Pharmasset's PSI 7977 BMS's Daclatasvir plus Asunaprevir Boehringer Ingelheim’s BI 201335 plus BI 207127 Danoprevir (formerly RG7128) Drugs to boost the immune response New interferons Alternatives to ribavirin Vaccines How drugs are licensed Drug trials and updates About clinical trials Liver Transplants Liver transplants introduction Opt in or opt out Who is eligible Assessment for transplantation The operation Recovering from the transplant Recurrence of HCV after the transplant Treating the recurrence of HCV Liver transplant statistics Treatment Diaries Nick's Treatment Diary Elizabeths Treatment Diary Sophies Treatment Diary Great News Treatment Q & A Professor Graham Foster 2005 Professor Graham Foster 2006 Professor Geoffrey Dusheiko 2006 Dr Kosh Agarwal 2006 Liver Nurse Consultant Angela Narbey 2006 Specialist nurse Yvonne Dawes 2005
Living with Hep C Caring for yourself Health Day Workshops Diet Diet Herbs and Supplements Juicing Juicing recipes Drink and drugs Alcohol Recreational drugs Smoking Health Managing pain An introduction to basic supplements Safe herbs for hepatitis C Stress Mental and emotional attitude A positive attitude Taking responsibility Emotions Understanding emotions Dealing with your emotions Dealing with bad days Other people Dealing with other people The dangers of being isolated Prevention Prevention Drug paraphernalia Around the home Mother to baby Body piercing, tattoos, electrolysis and acupuncture Medical and dental procedures Sexual transmission Sexual transmission - european study Doctors & Consultants Dealing with Doctors Problems with Doctors Dealing with Consultants Getting the most from Consultants Consultant checklist Sick certificates Access to records Alternative Medicine TCM - Traditional Chinese Medicine	Support Types of Support The importance of support Support groups Helplines Counselling and psychiatrists GPs and health advisors 12-Step fellowships Drug and alcohol support Expert Patients Programme Samaritans Services Hepatitis C Trust helpline Hepatitis C Trust support groups Hepatitis C Trust advocacy Setting up a support group Support Groups Setting up a support group Hepatitis C Trust support groups UK support groups Skipton Fund What is the Skipton fund? Skipton Fund New Compensation Announcement Skipton Fund - appeals panel The Caxton Foundation Counselling and support service Register with The Caxton Foundation	Get Involved How you can help us Campaigning Meet your MP Campaigning in the media Write to your MP Fundraising Fundraising Organise your event Thank you to our fundraisers Volunteering Become a Helpline Volunteer Become a Trust Volunteer Donate Donating by post Online Donations Regular donation by standing order What is gift aid? Join our Patients Association Share your story Healthcare Improvement Scotland Send us your story Personal Stories Anna's story Charles's story Charlotte & Nell's story Colin's story Gemma's story Jackie's story Jane's story Jayne's story John's story Keith's transplant story Michele's story Neil's story Petra's story Phil's treatment story Prison story Sam's story Saskia's story Susan's story Prison Story 1 The Consultant's Story World Hepatitis Day World Hepatitis Day 2011 WHD 2011 Testimonials World Hepatitis Alliance report 2011 WHD Events that happened around the country Birmingham Coventry Edinburgh Frimley Park Hospital Kingston Llanelli Nottingham Other events around the UK Reading Rochdale Westminster Drugs Project Yorkshire & Humber Great British C Party Organise your event Recipes - Starters and salads Gizzi's asparagus starter Francesco Mazzei's Blood orange salad Mark Hix's chicken liver and pomegranate salad Mark Hix's fish house salad Bryn William's Beetroot soup Leon's Original superfood salad Raymond Blanc's Watercress soup Other healthy salads Recipes - Mains Gizzi's roast shoulder of lamb Romy Gill's Baigan Bhartha Eddie Hart's John Dory with a fennel, chicory and radish salad Ken Hom's Steamed fish cantonese style Peter Gordon's broccoli, egg and cinnamon cous cous Peter Gordon's chilled beetroot and oat bran soup Antonio Carluccio's Fagottelli Di Granchio Friday Food Club's Lean Chicken Stew Selection of healthy soups Recipes - Desserts Gizzi's pannacotta dessert Bryony Edmunds - Pear, honey and polenta cake Joanna Pratt's Mango mousse Materials Register your interest Sadie Frost's Hep C Supper Club Gizzi Erskine's Hep C Supper Club Recipes Win a Juicer The 12 asks World Hepatitis Day 2010 World Hepatitis Day Parliamentary Reception Testing Van Tour 2010 'This Day' Music Album World Hepatitis Day 2009 UK Events Global Events Photos The Naked Scientists Get Tested! About Get Tested! Tattoo Infections YouTube videos Events An evening with Boy George at the Jazz Cafe Boy George press night 2010 Get Tested Auction IMS 2010 Get Tested Tom Jones Ibiza Space 2009 Inkie at IMS 2010 Paradise 2009 Ibiza 2011 Galleries Past WHD campaigns Patient Christmas Lunch South Asian Parliamentary Event July 2011 WHD 2009 Testing bus What Not To Share Photos What Not To Share Videos Alan McGee Andrew Loog Oldham John Tuvey from Flowered Up Kano Mr Hudson and The Library Pearl Lowe and Danny Goffey Pete Doherty The Genies The Mighty Roars The Rebeccas The What Not To Share Exhibition at City Hall 1.10.07 Tim Burgess You Me and Hepatitis C Bella Frued's 'Check it before you wreck it' Podcasts Lesley on WHD 2011 Testing bus 2010 World Hepatitis Day 2011 Shop Black check it T White check it T Basket Printed Wardrobe Events IMS 2012 Lance Loud: A Death in an American Family
News & Resources News 2012 February February First UK guidelines on new drugs New Hep C drugs to be given to Lothian patients January Benefits Hepatitis and HIV Can adding vitamin D improve response to HCV antiviral therapy? Alcohol Treatment Boosts Hep C Cure Rates Among Drinkers Hair we go says loving daughter New report published - HIV and Hepatitis C Co-infection Entry point of hepatitis C virus identified‎ High Rate of Sustained Response with Interferon Free Daclatasvir + Asunaprevir Achillion, Presidio, Idenix Announce HCV Drug Pipeline Developments Discussion on potential vaccine for hepatitis C Experts Issue Provisional Guidance on New Hepatitis C Drugs for HIV/HCV Coinfected Patients Fever Signals Responsiveness to Pegylated Interferon for Hepatitis C HCV ALL Oral Therapy Cured Without Peg/Rbv Hep C vaccine trial 'promising' Hepatitis B and C Are Major Causes of Liver Cancer Hepatitis C drug set to give Cardiff University financial boost Hepatitis C Virus Hijacks Liver microRNA How A New Antiviral Works More support for people with hepatitis C Scientists show brain vulnerable to Hepatitis C virus Sustained Response in Patients Treated with Telaprevir 2011 December Charity helps people live with Hepatitis C Telaprevir Effective in Hard-to-Treat Cirrhotic HCV Hepatitis C and Quality of Life Daclatasvir - High Rates of HCV Suppression Flavonoid found in green tea inhibits HCV virus High SVR Rates with Danoprevir for HCV Milk Thistle Extract Did Not Improve Quality of Life NS5A Inhibitor ACH-2928 Shows Potent Antiviral Activity November Achillion Finds Promising New HCV NS5A Inhibitor Candidate Daclatasvir plus Asunaprevir Rapidly Suppresses HCV in Prior Null Responders Drug-resistant Hepatitis C Hepatitis major public health problem in the North West High Rate of HCV Infection Shows Young Drug Injectors Need Better Prevention Interventions Interferon-free combination of BI 201335 plus BI 207127 and ribavirin New Approaches To The Treatment Of Early-stage Liver Cancer Pharmasset Starts Phase 3 Trials of PSI-7977 Without Interferon PSI-7977 Plus Pegylated Interferon/Ribavirin for Genotype 1 PSI-7977 plus Ribavirin Can Cure Hepatitis C in 12 Weeks without Interferon University Launches IPhone App for Hepatitis Treatment Upping Ribavirin Dose Does Not Increase Interferon Effectiveness in HIV/HCV Coinfected Patients October AASLD Hepatitis C Treatment Guidelines Updated to Include Boceprevir and Telaprevir Achillion Announces NS5A Inhibitor for the Treatment of Hepatitis C Adherence to Interferon-Based Therapy for Hepatitis C Slips Over Time Caxton Foundation and support service for patients who contracted hepatitis C via NHS blood or blood products Coffee Helps Reduce Side Effects in HIV/HCV Coinfected People during treatment FDA Approves Pegasys Autoinjector for Hepatitis C Patients Hepatitis C can be prevented by methadone plus needle exchange programs Hepatitis C in Scotland New Acute Hepatitis C Screening Strategy For HIV-Infected Patients People on Methadone Maintenance Can Be Successfully Treated for Hepatitis C Results from the Patient Needs Survey 2011 Telaprevir Shows No Problematic Interactions with Raltegravir Vertex to Test 12-Week Telaprevir for People with Favorable IL28B Gene Pattern Victrelis (Boceprevir) approved for NHS use in Scotland September BMS-790052 Demonstrates up to 83% SVR24 in Phase II Study of Genotype 1 Contaminated blood inquiry resumes hearing evidence Hep C weaknesses could lead to vaccine 'Hepatitis C has been accepted as not being a dirty word' ICAAC Maraviroc May Reduce Liver Fibrosis in HIV/HCV Coinfected People INCIVO® (TELAPREVIR) Approved in Europe New Pharmasset trials New support group for gay men coinfected with HIV and HCV Pharmasset Announces 91% SVR12 From the PROTON Trial in Subjects With Hepatitis C Genotype 1 Seasonal flu – get vaccinated if you have hepatitis C Vertex score big with hepatitis drug in America What Factors Influence Adherence to Treatment for Hepatitis C? When will the new drugs be available? August 10 Million Injection Drug Users May Have Hepatitis B or C 4-Drug Regimen Can Cure Genotype 1 Hepatitis C in 12 Weeks Bars sign up to Hep C drive 'Epidemic' of hepatitis C must be tackled now FDA Approves Pegasys plus Ribavirin for Children with Chronic Hepatitis C Hepatitis C cases in county near the 1,000 mark HIV Linked to False Negative Hep C Results Using Some Rapid Assays Killer virus sparks an epidemic of liver disease Liver disease in primary care conference 13th - 14th October Murdoch researchers attempt to thwart hep C virus New report on tattoo infections New treatment, 'Victrelis' (boceprevir), launched today for chronic hepatitis C genotype 1 Pharmasset's PSI-938 gets US FDA fast track status to treat chronic hepatitis C infection Public Lecture by leading experts in HCV field Radioembolization Improves Chance Of Survival For Liver Cancer Patients Saffron Shows Promise In Preventing Liver Cancer Scientists a step closer to Hepatitis C vaccine Study Suggests Obesity Accelerates Progression Of Cirrhosis Thousands in county are unaware they have deadly liver infection hepatitis C Victims of Tainted Blood in Cash Fight World Hepatitis Day Gets Global Recognition July 25% Increase In One Year For People Waiting For A New Liver, UK EU approves Merck's hepatitis C drug Victrelis (boceprevir) Health Minister to address hepatitis C epidemic hitting South Asian communities Hepatitis C Ups All-Cause Death Rate, SVR Reduces Mortality HPA New report on hepatitis C 2011 Ibiza Party wristbands now available July 28 Is World Hepatitis Day Pharmasset and Tibotec to try new drug combination for HCV Pharmasset Announces Final SVR Data From PROTON Trial In Subjects Infected With Hepatitis C Infection Genotype 2 Or 3 Sexual transmission of hepatitis C in gay men Third of the world infected with hepatitis: WHO TMC435 for HCV Gets Fast Tracked, Studied with PSI-7977 Viral Dominance in HBV/HCV Dual Infection When will the new drugs be available? World Hepatitis Day: The Hepatitis C Trust welcome Prime Minister’s call for more to get tested June BI201335 Shows Potent Activity against HCV Gregg Allman Plays NY Benefit To Fight Liver Disease Hepatitis testing schemes take off HOLVITA LIQUID COLOSTRUM PILOT STUDY New Discretionary Trust - The Caxton Foundation Pharmasset Announces the Expansion of the ELECTRON Trial in Chronic Hepatitis C May Boceprevir for HCV Wins Unanimous FDA Committee Recommendation FDA Committee Unanimously Recommends Telaprevir (Incivek) Longer Interferon Treatment Raises Hepatitis C Cure Rate Telaprevir (Incivek) Approved for Hepatitis C April BMS-790052/BMS-650032 Combo Cures Hepatitis C without Interferon Boceprevir Helps Hepatitis C Patients with Cirrhosis Boosted Danoprevir Improves Response in Prior Null Responders Bristol-Myers Interferon-Free Combo Cured Hepatitis Patients FDA Hearings on Boceprevir and Telaprevir for HCV New compounds show promise against hepatitis C infection Patients may have recieved incorrect test results in the Bristol area Sadie Frost, Boy George and Lisa Moorish raise £10,000 for the Hepatitis C Trust Tackling hepatitis C: a tale of two countries Tegobuvir Works Well in Triple and Quad Regimens for HCV March FDA Committee Sets Review Dates for HCV Drugs Boceprevir and Telaprevir Free testing events in Wales Interventional Radiology Y-90 Liver Cancer-busting Treatment: Safe, Fast, Extends Life Survey on hepatitis C - We need your voice! The Hepatitis C Trust back the Frontline First campaign February 10,000 Hepatitis C patients could hold the key to better treatment Alcohol swab recall alert Contaminated Blood Transfusions - Welsh Debate GET TESTED! An evening with Boy George and guests at The Jazz Cafe Kelly offers his support to hepatitis patients in Rutherglen and Cambuslang Little Change in Hepatitis C Risk among Injection Drug Users Sexual Transmission of Hepatitis C among HIV Positive Men in the U.S. and Australia This Morning TV - Boy George leads fight against Hep C Tibotec Starts Phase 3 Clinical Trials of HCV Protease Inhibitor TMC435 January Anemia during Hepatitis C Treatment Predicts Sustained Response to Pegylated Interferon/ribavirin Body Weight May Not Affect Hepatitis C Treatment if Ribavirin Dose Is Adequate Combating ‘the silent killer’: McGrigor pledges support for Hepatitis C patients Department of Health: New payment scheme announced for people with hepatitis C from contaminated blood European and United States Regulatory Submissions for Telaprevir Experts Devise Roadmap for Development of Direct-acting Hepatitis C Drugs HCV Polymerase Inhibitor INX-189 Looks Promising in Early Study Hepatitis C, BBC Radio 4 Latest - Hep C Trust in the news Vertex Ends Clinical Trial of Dual Telaprevir plus VX-222 Regimen Vertex says FDA will rule on telaprevir by May 23 Winning The Battle With Fibromyalgia 2010 December Menopause and Obesity Linked to HCV Relapse after Interferon based Treatment Pegylated Interferon Lambda for Hepatitis C Produces Good Response with Minimal Blood Toxicity All Star line-up serving hep C awareness Research Fuels Hope For Hard-To-Treat Hepatitis C Patients Artificial Liver Device Improves Survival for Hepatitis B and C Patients with Decompensated Disease Coffee Slows Progression of Hep C Liver Disease Sadie Frost: Father's death from Hepatitis C not pretty October Awareness raising day on the 27th October in Truro Can Chronic Hepatitis C Patients with Genotypes 2 or 3 Benefit from Shorter Interferon Treatment? Commons debate on blood scandal Help support the Tainted Blood campaign Hepatitis C Virus Causes Brain Inflammation Leading to Neuron Injury Insulin Resistance Linked to Poor Hepatitis C Treatment Response in HIV/HCV Coinfected Patients Millions of Americans Are Living with Hidden Epidemics Minister rules out higher pay-out for blood victims November Boceprevir Improves Response to Interferon-based Therapy and Allows Many Patients to Reduce Duration Direct-acting Drug Combos Suppress HCV without Interferon, but Resistance Remains a Concern FDA Approves Roche's Second-generation Hepatitis C Viral Load Test Hepatitis C fears prompt screening Protease Inhibitor TMC435 Shows Promise Against HCV in Phase 2b Study Results of Boehringer Ingelheim Oral Hepatitis C Protease Inhibitor and Polymerase Inhibitor Combination Phase Ib Trial Shows Rapid Viral Response Without Use of Pegylated Interferon Short-Course Telaprevir Equal to Full-Course in Some Patients With HCV Specialized Blood Vessels Jumpstart And Sustain Liver Regeneration Telaprevir Increases Sustained Response Rates and Shortens Treatment Duration for Newly Treated Hepatitis C Patients The Hepatitis C Trust makes the Clash blog The Hepatitis C Trust makes Vogue! Vertex Begins Trial of Telaprevir for Treatment-naive Chronic Hepatitis C Patients Vertex Completes New Drug Application for Telaprevir for Hepatitis C The Hepatitis C Trust welcomes review into support for those infected with contaminated blood Vertex Pharmaceuticals Announces Start of a Phase 3b Study of Twice-Daily Telaprevir in People Not Treated Previously for Hepatitis C September Bone Loss in HIV-Positive Men Tied to AIDS Diagnosis, Opiate Use and Hep C FDA Issues Guidance for Development of Directing-acting Antiviral Drugs for Hepatitis C Hepatitis C care quality condemned by MP Herbal Supplements Face New Scrutiny Holvita liquid colostrum can offer significant improvements in health Natural history of Hepatitis C Acquired through Injection Drug Use New Use for Old Drugs in Treating Hepatitis C NHS blood gave Cone Valley man HIV and hepatitis C Pegylated Interferon plus Ribavirin Has High Sustained Response Rates in Children with Hepatitis C Sadie Frost launches film competition on Hepatitis C Vertex, J&J Hepatitis C Drug Works After Others Fail Week 4 Rapid Virological Response Predicts Sustained Response to Interferon-based Hepatitis C Treatment August 60% rise in deaths from liver disease in last decade: hepatitis C is an increasing contributor The Hepatitis C Trust launches short film competition High-street hepatitis tests should be free on NHS campaigners say Pharmacy screening for hepatitis C could identify thousands more people with the virus PSI-7977 Receives Fast Track Designation From The FDA For The Treatment Of Chronic Hepatitis C Infection NICE Draft Guidance Gives People Living With Hepatitis C More Treatment Options Telaprevir Halves Hep C Treatment Time Highest Rates of Hepatitis C Virus Transmission Found in Egypt Pakistan Pharma to produce Pegylated Interferon locally Link Between Tattooing And An Increased Risk Of Hepatitis C New Anti-Viral Drug Shows Promise For Dramatic Improvement In Hepatitis C Treatment Calls For Hepatitis C Screening In Pharmacies HCV Survival in Syringes - The Beginning of a New Era in Understanding Hepatitis C Virus Prevention - EDITORIAL COMMENTARY Merck says hepatitis C drug meets study goals July Acute hepatitis C in HIV-infected men who have sex with men: an emerging sexually transmitted infection - Editorial Review Asian Patients Respond as Well as Whites to Interferon-based Therapy for Chronic Hepatitis C Chronic Hepatitis C Linked to Increased Risk of Kidney Cancer Chronic Hepatitis C Virus Infection Is Associated with Early Atherosclerosis Depression overlooked in patients with hepatitis C; compromising HCV therapy Direct-Acting Antiviral Drug Update from EASL: Part 2 Hepatitis C diagnoses reach record levels across Lothian Hepatitis Virus Transmission Through Misuse Of Anesthesia Is It Cost Effective to Treat HCV? Pair barred from seeing MP in protest T-shirts Response at Week 8 Accurately Predicts Sustained Response to Pegylated Interferon plus Ribavirin for Hepatitis C Sustained Response to Antiviral Therapy Prevents Esophageal Varices in Hepatitis C Patients with Cirrhosis June All-Party Parliamentary Hepatology Group back in action Blood-boosting Adjuvant Therapies Can Improve Response to Interferon-based Treatment for Hepatitis C FDA approves OraSure Technologies' OraQuick HCV Rapid Antibody Test HCV Polymerase Inhibitor ANA598 Demonstrates 75% Early Virological Response Rate in Phase 2 Trial HCV Treatment May Be Less Effective in an Urban Minority Population Hepatitis C and Diabetes: A Deadly Combination Hepatitis C treatment may depend on genetic variant Old Drugs May Have New Use Against Hepatitis C Reports of Hepatitis C Infection Among HIV-Positive Men Are Raising the Possibility That Hepatitis C May Pass During Sex Successful prevention of hepatitis C virus Sustained Virological Response at 12 Weeks Post-treatment May be as Good as 24 Weeks for Determining Interferon Cure The Emotional Impact Of Pain Reduced By Meditation May World Hepatitis Alliance Applauds World Health Assembly Decision Hepatitis C Bulletin: Beware of Eltrombopag Scotland - Hepatitis C awareness campaign Health workers hold special campaign across Bradford district Surrey doctors raise awareness about Hepatitis Get Tested! Hepatitis C Charity Hobnobbing Do Growing cases of hepatitis C Commencement Of Trials On Potent New Hepatitis C Drug Hepatitis C bespoke drug treatments North west figures released for world hepatitis day Latest Hepatitis C figures show year on year increase A New Coalition in Parliament HEPATITIS C LAWSUIT: Jury awards Henderson couple a record $500 million award Local parliamentary candidates make a stand for hepatitis C 75% of Treatment-Naïve Patients with Chronic Hepatitis C Achieve SVR (Viral Cure) with Telaprevir-Based Treatment in Phase 3 Trial Controlled Release Interferon (Locteron) Every 2 Weeks Works as Well as Pegylated Interferon but with Fewer Side Effects Many Genotype 1 Hepatitis C Patients Can Be Cured with 24 Weeks of Telaprevir plus Pegylated Interferon/ribavirin NICE revises hepatitis C treatments Nitazoxanide Increases Response to Pegylated Interferon plus Ribavirin in Treatment-naive and Non-responder Hepatitis C Patients Pegylated Interferon plus Ribavirin Works as Well in HIV/HCV Coinfected Patients with Cirrhosis Rifaximin Reduces Encephalopathy Recurrence, Improves Quality of Life in People with Liver Cirrhosis Screening for Liver Cancer in HIV/HCV Coinfected People April African-Americans and Hispanics Have Similar Poor Outcomes with Interferon-based Therapy for Chronic Hepatitis C Are Doctors Knowledgeable About Herbal Medicines? Campaigner wins tainted blood case Closely Individualized Treatment with Pegylated Interferon plus Ribavirin Is Possible Based on Baseline Viral Load and Early Response Experimental HCV Polymerase Inhibitor RG7128 Is Effective with Standard Therapy in Genotype 2/3 Patients Fundraising evening for hepatitis support group Glasgow witnesses called for HCV Therapeutic Vaccine GI-5005 Improves Rate of Sustained Response to Interferon-based Therapy for Hepatitis C Hepatitis C Infection Doubles Risk For Kidney Cancer Hepatitis C Virus Polymerase Inhibitor VX-222 Reduced Viral Levels Over Three Days In Phase 1b Trial Milk Thistle Silibinin Extracts Inhibit HCV Polymerase in Laboratory Study New hope for treating hepatitis C - Telaprevir Novelos Starts Phase 2 Trial of NOV-205 to Reduce Liver Damage in Non-responders to Interferon Therapy for Hepatitis C Operation in Pakistan saved my life but left me with legacy of Hepatitis C Skipton Fund review to be held earlier than expected World Hepatitis Alliance launches first major policy report on viral hepatitis March Abbott and Enanta To Start Phase 2 Trial of HCV Protease Inhibitor ABT-450 and Polymerase Inhibitors ABT-333 and ABT-072 Appetite-regulating Hormone Ghrelin May Inhibit Inflammation and Liver Fibrosis Artist raising awareness of hepatitis C Blood Contamination Bill Rejected Encouraging Data On Zalbin Famous author, actor and US national spokesperson for Hepatitis C Christopher Kennedy Lawford to visit Ukraine Groundbreaking Research To Find Vaccine For Hepatitis C Hepatitis C Treatments in Current Clinical Development Judicial review on tainted blood Link Between Hepatitis C And Insulin Resistance Surprises Scientists MP 'Ignored' Me MPs report back on the work of the All-Party Parliamentary Hepatology Group 'My lifestyle put me at risk' New Evidence for Milk Thistle New liver unit for Derriford New treatments on the horizon for hepatitis C Officials worried about saving money amid infected blood scandal Paying price of student days as 60% of Hep C sufferers unaware of infection Pensioner's disgust at diseased blood ruling Rock ‘n’ roll antics viral film warns of ‘silent disease’ Scottish Government Launches Campaign On Hepatitis C Scottish Government rules out pharmacy hepatitis C screening Surprising findings about Hepatitis C and insulin resistance Thousands unaware they have hepatitis USA - FDA Seeking Comments about Expanded Access for Direct-acting Antiviral Drugs for Hepatitis C Vertex Will Study All-Oral Regimen of HCV Protease Inhibitor Telaprevir plus Polymerase Inhibitor VX-222 February HCV Therapy Response Predicts Outcome in Co-Infected Patients £2.4m projected cost of treating Hepatitis C Guitar Legend Reveals Virus Shock Certain Syringes More Likely To Spread Hepatitis C Virus Among Drug Users Mosques play key role in raising awareness about hepatitis C Contaminated blood bill must become law HCV Drug Resistance Milk Thistle Nearly 2,000 Scots unaware they suffer from hepatitis C Norwich Hepatitis C sufferer demands justice Enzyme deficiency protects hepatitis C patients from treatment-related anemia Progression of Initially Mild Liver Fibrosis in People with Chronic Hepatitis January Management of Depression During Hepatitis C Treatment with Interferon-based Therapy Egypt - Hope against hepatitis C HIV/HCV Coinfected Patients with Persistently Normal ALT Can Develop Advanced Fibrosis, but Respond Better to Interferon based Therapy People Re-infected with Hepatitis C Are More Likely to Spontaneously Clear Virus, Indicating Partial Immunity Pharmacy testing pilot diagnoses 1 in 6 clients with hepatitis B or C Quercetin Appears to Block Hepatitis C Virus Production Liver Donations From Living Donors Increase 42% After Educational Intervention Sleep Disorders in People with Hepatitis C Hepatitis C group launches to aid thousands of Edinburgh patients Low-dose Pegylated Interferon Maintenance Therapy Does Not Reduce Clinical Outcomes despite Persistent HCV Suppression Management of Non-responders and Relapsers Treated with Pegylated Interferon plus Ribavirin for Chronic Hepatitis C Natural compound blocks hepatitis C infection Post-Transplant Liver Stiffness May Predict Fibrosis Risk A Liverpool doctor has been named as the Government’s first tsar for liver disease Department Of Health Appoints First National Clinical Director for Liver Disease New research finds promising treatment for hepatitis C New tests for ‘silent killer’ urged Pharmacy testing pilot diagnoses 1 in 6 clients with hepatitis B or C Randomized Study of Peginterferon-α2a Plus Ribavirin vs Peginterferon-α2b Plus Ribavirin in Chronic Hepatitis C Real-World Treatment Patterns, Non-Adherence, And Costs In Chronic Hepatitis C Engineering a new way to study hepatitis C Viramidine Fails to Show Non-inferiority to Ribavirin at Tested Doses but Causes Less Anemia 2009 December SPRINT-1 Study Shows Benefits of Response-guided Therapy with Experimental HCV Protease Inhibitor Boceprevir Hepatitis C warning over snorting cocaine Caution Hepatitis C and Vitamin D Deficiency Vitamin D Boosts Treatment of Chronic Hepatitis C Genotype 1 Chronic Hepatitis C Patients with Low Viral Load Can Achieve Sustained Response with 24 Weeks of Pegylated Interferon plus Ribavirin New drug technology produces marked improvement in hepatitis C therapy in animals Increase In Hepatitis C Diagnoses For 2008 in the UK North West continues to have highest figures in England for hepatitus C infections Toll-like Receptor Antagonist IMO-2125 Stimulates Production of Natural Interferons with Activity against Hepatitis C Virus Tripep Receives Approval for Expanding the ChronVac-C Study with One More Vaccination November Patients With More Difficult To Treat Forms Of Hepatitis C Are Half As Likely To Treat The Disease New hepatitis C protease inhibitors achieve 80% ‘cure’ rate in patients with genotype 1 infection Telaprevir - More Than 80 Percent Of HCV Genotype 1 Treatment-Naive Patients Achieved Sustained Virologic Response The Antifibrotic Effects Of Green Tea US - Medical Students Regularly Stuck By Needles and Often Fail To Report Injuries October Doctors and nurses on alert for hep C Drinking Coffee Slows Progression of Liver Disease in Chronic Hepatitis C Sufferers Hepatitis C emerges as Egypt's top health crisis Hepatitis C: Cost of Illness and Considerations for the Economic Evaluation of Antiviral Therapies If HCV Treatment Relapse Occurs, It Occurs Quickly Liver Cells Grown From Patients' Skin Cells Could Lead To Treatment Of Liver Diseases Patients hope new liver strategy will stop rising death toll from hepatitis C Shering Plough will present more data on Boceprevir at AASLD Short-Term Therapy for Patients with Hepatitis C Virus Genotype 2 or 3 Infection September HCV Viral Load Decline during the First 24 Hours of Interferon-based Therapy Predicts Long-term Outcomes in HIV-HCV Coinfected Patients Open Invitation to lecture at Oxford on 17th Sep HEPATITIS C VIRUS – CLOSER TO A CURE Researchers prolong the plasma half-life of biopharmaceutical proteins University Hospital Coventry unveils life-saving liver scanner August Hepatitis C virus channels efforts into cell survival New Strategy For Inhibiting Virus Replication Hepatitis C Treatment Gap May Be Solved by Genetic Finding University of Michigan Study Shows Chinese Acupuncture Affects Brain's Ability To Regulate Pain First human gets new antibody aimed at hepatitis C virus Summary of current clinical trials using Telaprevir for hep C Drug trial my last hope says Wibsey mum Eiger BioPharmaceuticals Acquires Exclusive License To Novel Hepatitis C Virus Technology From Stanford University July Investigating Why The Immune System Fails To Control Hepatitis C - Research consortium awarded 15 million dollars Hepatitis C Infection: Treatment Options Equally Effective, Likelihood Of Success Known Early On Government Response to Lord Archer’s Independent Report on NHS Supplied Contaminated Blood and Blood Products NHS failing to implement Hep C strategy leaving thousands at risk Press Release - Out of Control: Spiralling Number of Deadly Hepatitis C Infections As Government Strategy Fails 17 year old Jazzy de Lisser breaks taboos on hepatitis C Natural Course of Treated and Untreated Chronic HCV Infection: Results of the Nationwide Hepnet Greece Cohort Study Interferon-based Therapy Reduces or Reverses Liver Fibrosis over the Long-term in Chronic Hepatitis C Patients Early Bilirubin Elevation May Predict Severe Anemia during Interferon and ribavirin Treatment for Chronic Hepatitis C Hepatitis C Appears to Raise Risk of Cardiovascular Disease Laboratory reports of C infections January to March 2009 June The Clash's drummer Topper Headon makes peace with the man who sacked him Haemophiliacs protest to health minister Andy Burnham The C Watcher Hepatitis C Program Seeks To Help People Live a Better Life Metabolic Syndrome Is Associated with Increased Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients Does HIV-HCV Coinfection Increase the Risk of Liver Disease Progression and Worsen Clinical Outcomes? NEJM Study Points To New Era In Hepatitis C Treatment Tackling “Inadequate” Testing: Dried Blood Spot and Oral Fluids Bristol teacher: 'Transfusion gave me virus' May GET TESTED! - Celebs back Pleasley woman's Get Tested! Hepatitis C campaign GET TESTED! - Sadie and Ken Get Tested for Hepatitis C GET TESTED! - Hep C Trust launches pharmacy testing pilot World Hepatitis Day - Tackling "Inadequate" Testing: Dried Blood Spot And Oral Fluids Offer Chance To Extend Hepatitis Screening WHD - Kuwait first GCC country to join global bloc in fighting hepatitis 'Tainted blood' victim pledges to fight on for friends Haemophilia Society React To Government Response To The Archer Report WHD - World Health Assembly forced to postpone decision on viral hepatitis WHD - Hepatitis C Don't Feel Alone WHD - National Viral Hepatitis Roundtable Observes World Hepatitis Day and Calls for Increased Federal Action WHD - Woman raises Hepatitis awareness WHD - How do you know if you're at risk of hepatitis C? WHD - Actress Sadie Frost is urging people to be tested for hepatitis in Cardiff on Tuesday WHD - Celebrities ask 'Am I Number 12?' and GET TESTED for World Hepatitis Day WHD - New Zealand WHD - 6 per cent of population of Pakistan suffering from hepatitis C Hyperferritinemia Is Another Surrogate Marker Of Advanced Liver Disease Worldwide Success In Treatment Of Liver Tumours - Pioneering Technique Uses Microwaves EASL Analysis NATAP April London PCT recalls patients over hepatitis C test risk EASL - Some Highlights Laboratory reports of hepatitis C infection in England and Wales - third and fourth quarters 2008 EASL - Telaprevir Data Presented Show Unprecedented SVR Rates in HCV Treatment-Failure Patients in PROVE 3 Study EASL - Diabetes, Obesity And Hypertension Increase Mortality In Hepatitis C Patients More than $1.17 Million Funding for Hepatitis C NORWICH MUM RUNS MARATHON FOR HEPATITIS C Man's dying months will be a fight for compensation Treatment of chronic hepatitis C in Asia: when East meets West HCV Vaccine Development Studies Shed More Light on Acute Hepatitis C among HIV Positive Men in the U.S. and Europe Overview of the Current Standard of Care for Treatment of Chronic Hepatitis C Natalie Cole kidney failure after hep C treatment Australia - Tattooing blamed for rise in Hep C Team identifies a molecular switch linking infectious disease and depression Cirrhosis Regression in Chronic Hepatitis C: An Old Tale With a New Ending Therapy Affected By Mutations Within A Conservative Region Of Hepatitis C Virus Pegylated Interferon alfa-2a (Pegasys) Relapse Rates in Genotype 1 Chronic Hepatitis C Patients Depend on Weight-based Ribavirin Dosage Pete Tong Urges Clubbers To Take Hep C Test EDM - World Hepatitis Day 2009 Ireland - Toll from Hepatitis C infections revealed Re-Treatment With Pegasys Provides Hepatitis C Patients With A Second Chance For A Cure - Switzerland - New Study Wales - Bid to identify hepatitis sufferers March Michael’s battle for justice goes on VX950 improves cure rate in the most difficult-to-treat patients 2 day results predict ultimate response to therapy in chronic hepatitis C Hepatitis C patients who have failed treatment needed for UK trial using fish oils and statins Vertex announces acceptance of Telaprevir and VCH-222 abstracts for presentation at EASL Identification Of Key Molecules That Inhibit Viral Production May Aid In The Development Of Anti Hepatitis C Virus Drugs PUT YOUR PARTYING TO GOOD USE! Drugs team give out cocaine straws Study identifies human genes required for hepatitis C viral replication February January New deal urged for blood scandal victims Haemophilia patients infected with Hepatitis C and HIV 'should be compensated' Press conference on results of public inquiry into contaminated blood and blood products Probe Attacks NHS 'Bad Blood' Scandal Concern over Scots Hep C inquiry Free needles for drug users 'good use of NHS money' Bristol-Myers Squibb donates 1.17m dollars to hepatitis C projects More effort needed to curb hepatitis - experts A novel blood test could bring a breakthrough in the battle against the hepatitis C virus Cyclical Treatment Interruption in Patients Taking Interferon-based Therapy for Chronic Hepatitis C Busting the myths about hepatitis C Hepatitis C Virus May Persist at Low Levels after Sustained Response to Treatment; Liver Cancer May Develop Years Later Extra nurses to help fight hepatitis C Unaware of hepatitis C for 20 years Divided Nations - Tackling the hepatitis C challenge across the UK Wales: Campaign demands renewed urgency in tackling hepatitis Ireland : Facing up to the blood-bank crisis A Rigorous Method For Liver Biopsy New Imaging Identifies Types of Liver Disease Initiation Of Phase 2b Trial Of Albuferon Dosed Monthly In Chronic Hepatitis C Announced Ireland - Hep C scandal New Department of Health awareness campaign launches early Feb Government looks to make noise on silent virus Statement On Liver Transplants - Royal Free Hampstead NHS Trust England Update on VX950 clinical trials 2008 December Deaths from hepatitis C - A legacy of our past behaviour Albuferon Meets Primary Endpoint In Phase 3 Trial In Chronic Hepatitis C Maintenance therapy doesn't work I had to have a new liver, but I still don't believe that 'presumed consent' is right, says transplant recipient Prodrug Taribavirin Produces Equivalent Response, but Less Anemia than Ribavirin at 48 Weeks November Healthcare staff at risk of infections through needle injuries Schering Plough Provides Update On Boceprevir Clinical Development And Introduces Potent Next Generation Oral HCV Protease Inhibitor Tibotec Begins European Enrollment For Phase 3 Trial Of Telaprevir In HCV Patients Who Failed Prior Treatment Systems Biology Brings Hope Of Speeding Up Drug Development Who Will Respond to Hepatitis C Treatment Study Shows Soviet-Era Dietary Supplement Boosts Immune Activity Stem Cells With Potential To Regenerate Injured Liver Tissue Identified By Penn Researchers Tripep’s ChronVac-C treatment shows antiviral effect in patients with chronic hepatitis C also in the high dose I Feel My Liver Donor's Presence Roche InterMune and Pharmasset Announce Initiation of INFORM-1 the First Dual Combination Clinical Trial with Oral Antivirals in Hepatitis C I caught hepatitis C at birth but now I'm cured Patient education improves adherence to peg-interferon and ribavirin in chronic genotype 2 or 3 hepatitis C virus infection: A prospective, real-life, observational study Nurses 'in fear' of needle injuries Inside-out cells offer target for antiviral drugs NHS Tayside’s £2.7m to fight Hepatitis C Tainted Blood - A Family Story UK Experts Warn About Untested Remedies And Issue Guide To Consumers October Higher Doses of Pegylated Interferon and Ribavirin May Increase Sustained Response Rates in Hard-to-Treat Patients with Chronic Hepatitis C Lower-than-standard dose peg-IFN alfa-2a for chronic hepatitis C caused by genotype 2 and 3 is sufficient when given in combination with weight-based ribavirin Symptoms Of Major Depression Relieved By St. Johns Wort Association of British Insurers has no guidelines for hep C within life assurance industry Liver Disease On The Rise But New Treatments Coming Natalie Cole is on bed rest following a setback in her battle with Hepatitis C Urgent need for action to tackle hepatitis C Ribavirin plus interferon versus interferon for chronic hepatitis C Breath Test for Non-invasive Assessment of Liver Fibrosis in Chronic Hepatitis C Patients US company awarded grant to research cell based therapy for hepatitis C September Duke NCRC researchers studying Natural Prevalence of Resistance to HCV Protease Inhibitors Results From Phase 2A Clinical Trial Using SCV-07 As Monotherapy In Patients With Chronic Hepatitis C Infection VCCP set to scoop DoH hep C account Telaprevir Presentations at the 59th AASLD Meeting Natalie Cole hospitalized due to hepatitis C treatment Survey crackdown on killer virus world first for Holyrood Family Hepatitis Service at St Marys, Paddington Hepatitis C patients may have abnormal blood sugar levels In France successfull treatment is reducing mortality due to Hepatitis C Evidence to support belief in transmission of hepatitis C by sharing drug sniffing equipment Vertex Fending Off Competitors By Treating The Toughest Patients With Hepatitis C Improved Tool To Rank Sickest Patients Waiting For Liver Transplants Developed By Mayo Clinic Doctors should be trained to diagnose and treat hepatitis C NHS gave me the big C but won't save me Changes in Mood States During Peginterferon and Ribavirin Treatment of Chronic Hepatitis C Fibroscan Research genes can predict tx outcome August Hep C Story Saved My Life Open period for Hep C insurance scheme closing soon Liver damage in hepatitis C patients could be treated with warfarin says study Government Must Vaccinate All British Children Against Hepatitis B Body Puts Cells 'Under Arrest' To Protect Against Liver Disease Blood team's work is heralded Vertex to commence Phase 3 Telaprevir trials Victims of Britain's tainted blood scandal speak Court Upholds Compensation Cut-off For NHS Hepatitis Victim Olympic athletes warned about hep C 74 percent of patients achieved SVR 12wks post treatment with 48 week boceprevir based combination therapy Ministry Wavers on HCV Visa Ban Thousands at risk of deadly virus as GPs misread hepatitis C test results In Transplants Older Livers Not So Different Than Younger Ones GPs on the spot over blood tests Found needles pose low infection risk for children Boceprevir shows promising results Early treatment is key to combating Hepatitis C virus - Researchers publish research results in on-line edition of Journal of Virology July Improved Culture System for Hepatitis C Virus Infection Enzyme may explain how hepatitis C infection causes fatty liver Natalie Cole diagnosed with hepatitis C Sick and down Stem Cell Research for treatment of hepatic diseases Future of Hepatitis C patients in UAE hangs in ministerial balance Adequate Ribavirin exposure after the first dose predicts SVR in genotype 1 patients Hepatitis C Vaccine Shows Increased T Cell Responses And Reduced Viral Loads Studies look at effect of lower doses of Peg-Interferon and Ribavirin for people with Genotypes 2 or 3 June Vertex announces new trial of telaprevir in non responders Vertex CEO preparing for 09 hepatitis drug launch Very Early Response to Interferon-based Therapy for Hepatitis C Is Apparent within the First 24 Hours Course of Chronic Hepatitis C in Children Central Asia: World Bank Warns Of Tainted Blood Transfusions Across Region Poly-MVA - The First Dietary Supplement To Be Cleared By The FDA For Use In A Cancer Study For Patients with HCV Genotype 6 - 48 Weeks Treatment is Superior to 24 Weeks Active and Recovering Injection Drug Users Can Benefit from Hepatitis C Treatment if They Maintain Good Adherence Will Vertex seek regulatory approval for telaprevir in 2009? Vertex reports on Prove 3 interim results Herbal Product Stevioside Inhibits HCV Replication and Curcumin Suppresses Fibrogenic Cell Activity in Laboratory Studies Last public hearing of independent public inquiry into Contaminated Blood and Blood Products Selective hepatitis C screening for pregnant women isn't working Tattoed Irish Should Be Tested for Hepatitis C Mortality Due to Hepatitis C in the U.S.: Has the Worst Passed? Eltrombopag Trial Results Parliamentary Debate on Liver Disease May New Hope for Liver Diseases Blood victim backs campaign Fundraise for the Trust and win some designer goodies! Schering Plough starts hepatitis C Boceprevir Phase III trials earlier than expencted United by hepatitis c Australia - The tattoo craze that is exploding among young people has also led to an alarming surge in hepatitis, health experts have revealed. Frequency distribution of hepatitis C virus genotypes in different geographical regions of Pakistan and their possible routes of transmission Hep C Drugs Slug It Out Cryoglobulinemia - New Theory Suggests How Hepatitis C May Cause Rare Immune Disease Educational DVD wins awards April EASL - Important Progress Toward Control Of Hepatitis B And C EASL - Telaprevir (VX950) Prove 1 and 2 Results EASL - Positive Findings In Treating Patients With Advanced Hepatitis C EASL - R1626 has shown a significant end-of-treatment response rate EASL - SVR Is Dependent On Baseline Characteristics In The Retreatment Of Previous Nonresponders EASL - Interim Results From Boceprevir Phase II Study In Genotype 1 Treatment-Naive Hepatitis C Patients EASL - HCV Genotype 2 And 3 Respond Differently To Anti HCV Treatment The Cure That Kills Daughter fulfils her promise HPA - Hepatitis C Testing Oct to Dec 2007 Researchers Identify Treatment Target For Liver Cancer Recurrence And Survival For Patients With Advanced Liver Cancer - Hope Found In Combination Therapy Milk Thistle Research - Herbal product use by persons enrolled in the HALT-C Trial Scottish Health Secretary Nicola Sturgeon Announces Public Inquiry United Arab Emirates adds Hepatitis C to list of deportable diseases Temporal trends in hepatitis B and C Infection in family blood donors from interior Sindh Pakistan Pakistan - Premier’s programme for hepatitis control failing seven million patients Valeant Reports Promising 12-week Phase IIb Data on Taribavirin March USA - The FDA Approves New Weight-Based Dosing Regimen for PegIntron plus Ribavirin GPs need new liver function guidance say experts HCVAdvocate Newsletter Gregg Allmann feeling the effects of hepatitis C treatment US - Health inspectors scrutinize 3 clinics Research - Cholesterol lowering drug offers hope in treating hepatitis C (4 news stories) Big increase in hepatitis C-related deaths in the United States Research - Scientists develop a process to disrupt hepatitis C virion production Study Examines Persistent Hep C Infections in IV drug use Ignorance blamed for prevalence of Egypt hepatitis C Help needed for new report on the prevention of Hepatitis C Medicine and Me: Hepatitis C Link between immigration and hepatitis C examined Update: what you need to know about grapefruit and hepatitis C FibroScan for diagnosis of fibrosis in patients with recurrent hepatitis C post transplant and acute viral hepatitis Drug Trials - Taribavirin Showing Lower Anemia Rates than Ribavirin Las Vegas clinic shut after hepatitis C infections February Update on VX950 and Albuferon drug trials Phase IIa study with Locteron for the treatment of hepatitis C commences patient dosing Insulin resistance tied to hepatitis C infection Study announced into interferon response in hepatitis C patients Lack of inmate treatment costs state $8M in lawsuit Inaugural Roddick award for trust Hepatitis C infection may be blocked by grapefruit compound Drive To Treat And Prevent Hepatitis C Contaminated Blood Husband blast on Anita's bug Serum fibrosis markers correlate with liver fibrosis stage in patients with advanced chronic hep C January Expert calls for early diagnosis and treatment of hep C Move for prison needle exchange Crack pipes can transmit hepatitis C virus HCV genotypes 2 and 3 do not respond the same to interferon-based treatment HPA Laboratory reports of hepatitis C infection in England and Wales July to September 2007 HPA Surveillance study of hepatitis testing in England data for July to September 2007 Human Genome Sciences modifies dosing in Achieve trials of Albuferon Phase 3 trials of telaprevir (VX950) announced In largest U.S. hepatitis C trial researchers determine weight based dosing Is key to optimal treatment Duration of pegylated interferon plus ribavirin may be tailored based on early patient response Canadian cleared in tainted blood case For Liver Cancer identification proteomic profiling is more accurate than traditional biomarkers Medical Safety Technologies introduces revolutionary safety syringe Extra-hepatic manifestation of hepatitis C virus infection World Hepatitis Day News MEPs call for EU action to tackle hepatitis UK - The Other 'Big C' UK - GPs Sign Up To Combat 'Silent Killer' Disease Ireland - 20,000 people may be infected with 'silent killer' hepatitis C Scotland - Plan to boost number of hepatitis C sufferers receiving treatment UK - GPs spearhead fight against hepatitis C UK - Teacher's Hep C shock Australia - Raising awareness and political attention for chronic viral hepatitis Australia - World Hepatitis Alliance Calls On Governments To Take Urgent Action Pakistan - Experts call for measures to fight killer disease USA - DHEC Hosts Free Hepatitis C Testing UK - Dovercourt: Living with hepatitis C UK - Daily Mirror health topic: The silent killer that lies in wait for years UK - My life with Hepatitis C Channel 4 News - Up to one in 12 people infected with hepatitis New Zealand - Today is World Hepatitis Day UK - Health Protection Agency welcomes World Hepatitis Day 1 in 12 Infected With Hepatitis Global groups slam hepatitis C ban USA - Students Bake Cookies For World Hepatitis Awareness Day News From AASLD Liver Conference 2008 AASLD 2008 - Outcomes of Acute Hepatitis C Virus Infection in People with HIV AASLD 2008 - Genotype 1 HCV Patients with Early but not Rapid Response May Benefit from 72 Week of Pegylated Inte AASLD 2008 - HCV Protease Inhibitor Telaprevir (VX-950) Continues to Perform Well in PROVE Trials AASLD 2008 - Intravenous silibinin for treatment of nonresponders to peginterferon/ribavirin therapy in chronic hepatitis C AASLD 2008 - IDEAL Researchers Look at Predictors of Response to Pegylated Interferon plus Ribavirin including race ethnicity and anemia AASLD 2008 - HCV Protease Inhibitor Boceprevir plus Pegylated Interferon/Ribavirin Increases Sustained Virological Response Rate: SPRINT-1 Study AASLD 2008 - Efficacy of Initial Treatment May Predict Long-Term Outcome in Chronic Hepatitis C Patients: Presented at AASLD AASLD 2008 - HCV Polymerase Inhibitor R7128 Demonstrates Good Antiviral Activity in Genotype 2 or 3 Prior Non-responders and Relapsers 2007 December Expert Calls For More Testing Study Affirms Crack Pipe Link to Hep C HPA Hepatitis C in England Annual Report Dec 2007 Conference coverage from the AASLD Liver Meeting 2007 Hepatitis C - staying the course Treating patients with psychiatric disorders for hepatitis C Scotland - Campaign to raise awareness of Hepatitis C among health professionals is stepped up November Evel Knievel Dies WHATNOTTOSHARE - Silver Sniffers Drug boosts platelets in hepatitis C patients Artificial liver offers sufferers new hope Researchers Find New Seventh Genotype Epidemiology and Treatment Response of Genotype 5 HCV Of course I have regrets says Marianne Faithfull on a life packed with bad living Hepatitis C researcher to receive prize Gambling with blood money First Peginterferon Therapy Approved for Retreating Both Hepatitis C Relapsers and Nonresponders Significant Anti-Cancer Effects Of Milk Thistle Domonstrated By Scientists Department of Health awareness campaign update what not to share photo exhibition Hepatitis C virus found to spread directly from cell to cell by-passing antibodies Business website reviews hepatitis C drugs AASLD 2007 - Drugs in Development Results from Phase 2 clinical trials of telaprevir (vx950) The American Liver Foundation Encourages Heightened Awareness Of Hepatitis B And C In Light Of Recent Events In The News October Half of UK Students at Risk of Silent Time Bomb Disease Infections among injecting drug users in the United Kingdom 2006 Health News - Organic produce has a higher nutritional value than ordinary food Liver Fibrosis Predicted by MRI Safe syringe could avert 1.3 million deaths yearly Rallying call in tribute to Roddick Hepatitis C Testing Recommended For Anyone With A Tattoo Weight-based dosing of ribavirin improves outcomes for patients with hepatitis C Locteron – a controlled release interferon - Phase 2a Hepatitis C Trial Results selected for presentation at AASLD Conference Marianne Faithfull Suffering From Hepatitis C ‘Get Tested’ - World Hepatitis Awareness Day Liver Transplantation Successful In Over 60's Treatment Outcomes in HCV Patients Whose Therapy Is Supervised by Expert Hepatologists Canada - Tainted blood verdict angers victims Non-Invasive Tests for Cirrhosis May Help to Avoid Liver Biopsy October 1st BBC Video News Caring for People with Hepatitis C Students Warned Over Hep C Risk September Dispelling myths helps sufferers of quiet killer The other big C Vertex Announces Publication of Abstracts for Presentation at 58th AASLD Meeting August Researchers turn mouse into factory for human liver cells Beating a stigma and staying alive Details on outcomes of hepatitis C compensation claims ordered to be disclosed Reduced Risk Of Liver Cancer Linked With Coffee Consumption Calls to tackle Hep C HCV Advocate Newsletter Aug 2007 July Dr Brian Iddon MP backs hepatitis campaign calls Enhanced Liver Fibrosis (ELF) test available in Europe Laboratory reports of hepatitis C infection in England and Wales January to March 2007 Hepatitis C helicase unwinds DNA in a spring-loaded 3-step process Phase 2a trial results of Locteron - a controlled-release interferon Scottish Cabinet Secretary for Health takes part in awareness raising walk Hepatitis C strongly linked to type 2 diabetes Pay-out for misdiagnosis by doctor Chief doctor calls for organ donation by default Mathematical Model Identifies Genes which Battle Hepatitis C Fighting drug resistance in hepatitis C virus Infected blood - the American filmaker and allegations of cover up BBC Celebrity Health - Anita Roddick GPs warned of Hepatitis C crisis HCV Advocate - Journal Review July 2007 Study finds variable drug sensitivity among hepatitis C viruses HCV Treatment Genotypes 2 and 3 — How Short Can We Go South Asian music resource tackles hepatitis C awareness Lord Owen claims officials knew of hepatitis risk Blood test detects fibrosis Numerous factors affect success of interferon treatment for hepatitis C June Cancer drug extends survival in liver cancer patients Ending the stigma of a devastating blood virus Government must co-operate with haemophilia inquiry HCV Advocate - Journal Review June 2007 HCV Advocate - Journal Review June 2007 HCV Advocate - News Review 25th June 2007 HCV Advocate - News Review 25th June 2007 Hepatitis C - stealth killer Hepatitis C project launched Hepatitis C project launched HPA - Hepatitis C lookbacks India - Roche`s Hepatitis C drug patent challenged Pathogenesis of Hepatitis C Virus Coinfection in the Brains of Patients Infected with HIV Pathogenesis of Hepatitis C Virus Coinfection in the Brains of Patients Infected with HIV Prescription charges for chronically ill patients to be scrapped in Scotland Results of phase II trial of Valopicitabine Safe blood for safe motherhood 'Sufferers died in vain' WHO launches safe blood drive Women offered hepatitis C screening May BBC News Online - 'Louie, Me and Hepatitis C' Canada - Nurses Demand Safer Needles China tackling tainted blood products industry Harm reduction action plan HCV Advocate - Journal Review May 2007 HCV Advocate May 2007 Newsletter HCV Advocate Newsletter and DDW Conference Abstracts HCV Advocate weekly news review Hepatitis C Council of NSW Newsletter Hope For Blood Patients Horror of hepatitis timebomb Illegal tattooist reused needles Liver stiffness indicates severe portal hypertension in patients with hepatitis C-related cirrhosis Lord Archer Inquiry into contaminated blood & blood products Milk Thistle exerts anti-inflammatory and anti-viral effects New Medical Research Engine New test for liver disease Number 10 hiding blood scandal facts Schering-Plough Announces Hepatitis C Data Presentations At Digestive Disease Week (DDW) 2007 Annual Meeting Scotland - Ministers agree to inquiry into blood contamination The Mirror - Sharing a Toothbrush April Business Articles on VX950 Charity manager jailed for theft Contaminated blood inquiry begins Film follows life of Hepatitis C sufferer Hepatitis A And Hepatitis C Attack Same Protein To Block Immune Defenses, Scientists Find Live presentation on VX950 from EASL 2007 New Zealand - First One-Off Payments Offered Phynova sees at least 3 products in clinical trials by year-end Protein Found That Slows Hepatitis C Growth In Liver Cells Tests of clotting agent 'led to 2,000 deaths' The Guardian - Widow accuses doctors over donor blood risks US liver center leading record number of studies to tackle hepatitis C VX950 - Interim Results Presented at EASL from PROVE 1 Clinical Trial March Hepatitis C mentioned during Health Debate-House of Commons 22nd Feb 2007 New culture system leads to anti-viral treatments for hepatitis C No Risk From Hepatitis C dentist February Antipodean Pharmaceuticals Initiates Phase 2 Trial In Hepatitis C At least five million people in Egypt are infected with the hepatitis C virus Bloody hell Bloody Hell: Body Shop founder's new battle Dame Anita Roddick demands more government action to compat hepatitis C - Declares personal interest Dame Anita Roddick Hepatitis C and Me HCV Advocate - Journal Review Feb 2007 Health Protection Scotland (HPS) reports data on hepatitis C diagnosis Hepatitis C: The Secret Assassin Irish biochemist in anti-D case 'will not get a fair trial' Lessons Learned From Liver Retransplantation Medical News Today New documentary film about hepatitis C- 'Louie, me and Hepatitis C' Scotland : Hepatitis C alert as cases of hidden killer hit 19,000 Viruses on show as art - and scientists help January 10,000 people exposed to Hep C in Dublin Cheap drugs for poor nations Fears over drinking habits as liver disease deaths double Fighting the enemy within HCV Advocate - News Review 4th Janaury 2007 Heavy Drinking Takes Excessive Toll on Women With Hepatitis C Hepatitis breakthrough at University of Washington HIV/HCV coinfected individuals have an increased risk of cardiovascular disease Last Christmas Mid-lifers most likely to have injected drugs Northern Ireland - Hepatitis C Action Plan published today 17th Jan Racial differences seen in steatosis in patients with hepatitis C Research News - 'on/off switch' controls immune defenses against viruses. The American Liver Foundation Warns Of An Increase In U.S. Liver Cancer Deaths 2006 December European Parliament Written Declaration on Hepatitis C Fears over hepatitis C awareness Help needed for silent disease Hepatitis C petition on the Prime Minister's website Hepatitis C Trust statment on HPA report Hepatitis tests 'like witch hunt' HPA Hepatitis C report 2006 New Zealand - $30m Hep C blood supply infection compo Scotland - Clinical guideline published on management of hepatitis C Scotland - Testing for hepatitis C extended to risk groups The Sunday Times - A dangerous line? Times hepatitis supplement VX950 - safety analysis from phase 2b clinical trial November Discovery Reverses Thinking About Hep C Treatment for Drug Users Hepatitis rebound seen after treatment "success" HPA report - exposure to bloodborne viruses in healthcare workers HPA report on infections among injecting drug users in United Kingdom Integrated care improves chronic hep C outcome Next dates for DOH FaCe it campaign Rogue tattooist scare for schoolgirl Too many healthcare workers exposed to bloodborne viruses Wales - 15,000 may be hepatitis carriers October APPHG - Expanding The Options Association Between Intranasal Drug Use and Hepatitis C Virus Infection Drug users could have deadly virus First liver transplant for HIV patient HCV Advocate - Conference coverage from AASLD, Boston Hepatitis C Action Plan receives executive money after protests Hepatitis C Awareness Telethon to Air it's 3rd Annual Broadcast Live on the Internet Ireland - 580m is paid out to Hep C patients over contamination Ireland - Children's hospital says sorry over Hepatitis C risk 'Shared banknote' health warning to cocaine users. Skipton Fund Appeal Panel update - October 2006 Steven Tyler Praised by International Patient Groups There is life after hepatitis C What not to share - Time Out WHATNOTTOSHARE - DJMagazine September BE AWARE OF HEPATITIS Bringing People Together Fighting Threat Of Virus Fighting Threat Of Virus HCV Advocate - Journal Review Sep 2006 HCV Advocate - Journal Review Sep 2006 HCV Advocate - Journal Review Sep 2006 Lothians gets cash boost to fight hepatitis C Prisoners will get drug-taking kit to help prevent spread of HCV Prisoners will get drug-taking kit to help prevent spread of HCV Raising awareness of hepatitis Scottish Executive today announced a 4 million action plan to tackle the virus Skipton Fund Appeal Panel appointed Steve Tyler Study: Medical marijuana can help people with hep C Study: Medical marijuana can help people with hep C The Secret Shock of hepatitis C Warning on the silent killer Warning on the silent killer WHO Europe concerned about high levels of hepatitis C infection World Hepatitis Awareness Day August DOH FaCe It awareness campaign in Southampton 17th & 18th August Hepatitis appeal from MP Richard Younger-Ross It's time to get yourself tested for hepatitis C, says maths professor Peacock Project hepatitis C information stand at Peoples Park Festival Aug 13th 'Postcode Lottery' for disease victims Racial differences in hepatitis C viral responses Radical changes for organ donors The Hepatitis C Trust media statement on NICE guidance for mild hep C Thousands with hepatitis C to benefit from new NICE treatment guidance Unregistered tattooists could be dangerous WORLD HEPATITIS AWARENESS DAY 2006 (WHAD) July Canada - Hepatitis C victims to get payout of $1billion Canada offer over blood scandal European Parliament approves needlestick protection report Justice For Mum Patients rubbish health dept's Hepatitis C survey - The Times of India PCTs are 'failing to tackle hepatitis' Positive tests in hepatitis C alert Report from 2nd International Conference on Hepatitis C in Dublin 21st-23rd June 2006 Stay healthy in 15 unlikely steps June Blood scandal families' fury at inquiry refusal Blood scandal families' fury at inquiry refusal Government hepatitis C awareness exhibition in Norwich Fri 9th & Sat 10th June HCV Advocate - News Review 24th June 2006 HCV Advocate - News Review 24th June 2006 Hep C Stigma Spreading Kerr rules out blood virus probe Kerr rules out blood virus probe MP criticises hepatitis handling Mum's battle against virus for 33 years Mum's battle against virus for 33 years Obesity tied to hepatitis C treatment failure Rush for blood tests after hepatitis C scare Watchdog review of hepatitis case Watchdog review of hepatitis case We must beat hepatitis C stigma May BBC News Online:Thousands in hepatitis c screening Copies of lost 'blood row' papers found Doctors make recommendations to Government on hepatitis C care 'Lottery' of liver virus NHS 'failing hepatitis C victims' Radio 4 broadcast play based on hepatitis C treatment blogs Report shows PCTs failing hepatitis C patients-An audit by the APPHG Reports from EASL 26-30 April 2006 Reports from EASL 26-30 April 2006 Tainted blood victims 'were not informed' Sunday Observer Walk of LIfe April Fresh calls for public enquiry Fresh calls for public enquiry Hepatitis C clinical trial excludes African Americans Hepatitis C clinical trial excludes African Americans Left to die: the hidden victims of an NHS blunder Left to die: the hidden victims of an NHS blunder Potential new approach to treating hepatitis C. Potential new approach to treating hepatitis C. Safety fears over plasma products The Ongoing Scandal The Ongoing Scandal Trek of a lifetime to raise awareness of hepatitis C Trek of a lifetime to raise awareness of hepatitis C March 15th March-HCV Nurse Siobhan Fahey leaves on fact finding trip to Pakistan Blood death: Familys 'whitewash claim Claims of mail tampering in legal battle over blood products FaCe It awareness campaign-photography exhibition in Liverpool Wed 15th and Thurs 16th March FaCe It awareness campaign-photography exhibition in Manchester 31st March/1st April Haemophilia Society condemns DH review of blood related infections HCV Advocate - Hepatitis C in Children Update 2006 HCV Advocate - News w/e 18th March HCV Advocate - News w/e 18th March Nature magazine - critical review of important current developments Picture power highlights fight against hepatitis C Skipton Fund Update Skipton Fund Update UK Hep C Mentoring Conference - Glasgow 24th March 2006 Update on Albuferon - interim results of phase II trial. February Genotype 1 virus grown in lab for first time Genotype 1 virus grown in lab for first time Hepatitis C recurs rapidly after liver transplant Hepatitis C recurs rapidly after liver transplant My dad was dying and we never knew My dad was dying and we never knew News and Highlights from website HCV Advocate News and Highlights from website HCV Advocate Thousands infected from blood transfusion Thousands infected from blood transfusion January 'Destroyed' files key for patients given infected blood Files On Infected Blood Destroyed - BBC News Hollywood follows trail of blood - Canada's tainted blood scandal to become big screen drama House of Commons-Questions about destruction of papers related to contaminated blood products Large clinical trial to evaluate low dosage interferon maintenance therapy in HCV/HIV co-infected patients Researchers use new approach to 'break the code' for liver cancer test 2005 December BBC News Online - Hepatitis C 'affecting thousands' Daily Mail -"Thousands Living With Hepatitis C" Guardian 14/12 'Deaths from Hepatitis C double' Health Protection Agency launches report Important and interesting abstracts from recent AASLD conference in USA Important and interesting abstracts from recent AASLD conference in USA Latest Abstracts from Medical Journals New cases of hepatitis C have soared in the North East over the past decade November Breastfeeding does not raise risk of HCV transmission Hepatitis C and the Thyroid Gland Latest Abstracts from Medical Journals Liver Treatment Lifeline For Scots Liver Treatment Lifeline For Scots Many prisons failing on HIV and hepatitis C Many prisons failing on HIV and hepatitis C Portraits highlight 'hidden' infection Portraits highlight 'hidden' infection October 13th October - Recent Abstracts from medical journals 19th Oct - Latest Abstracts from medical journals Biomarkers used to predict recurrent disease in hepatitis C transplant patients Giving up anonymity to fight Hepatitis C Giving up anonymity to fight Hepatitis C Hepatitis C Campaign Targets East London Hepatitis C linked to illegal blood donation in China Japanese research team says it has found method to stop hepatitis C virus multiplying Japanese research team says it has found method to stop hepatitis C virus multiplying Latest Abstracts from Medical Journals New hope for liver transplant patients Next FaCeIt exhibition in Portsmouth 4th and 5th November Shorter course of treatment approved for cetain HCV patients with genotype 1 and low viral load UK Liver care 'failing patients' UK Liver care 'failing patients' September Delivering the ELPA petition to number 10 Downing Street Effect of ondansetron, a 5-HT3 receptor antagonist, on fatigue in chronic hepatitis C Is Cirrhosis an Inevitable Consequence of Chronic Hepatitis C Virus Infection? Journal of Hepatology - latest edition with abstracts Olive oil contains natural anti-inflammatory agent Olive oil contains natural anti-inflammatory agent Pharmacists able to detect 'hidden' hepatitis c in drug users Recent Abstracts from medical journals Recent Abstracts from medical journals Study looking at combination treatment for 12 weeks versus 24 weeks in HCV Genotype 2 or 3 Study suggests cirrhosis and liver disease nearly inevitable for people with hep C Study suggests cirrhosis and liver disease nearly inevitable for people with hep C The UK vs. Europe Losing the Fight Against Hepatitis C Value of non-invasive methods (Fibroscan + FibroTest) to detect fibrosis progession in patients with normal ALT levels Value of non-invasive methods (Fibroscan + FibroTest) to detect fibrosis progession in patients with normal ALT levels August Awareness campaign highlights blood disease-Brighton Argus Awareness campaign highlights blood disease-Brighton Argus FaCe It awareness campaign photography exhibition next venue - Bristol FaCe It awareness campaign photography exhibition next venue - Bristol HIV/HCV coinfected patients do not have an increased risk of HIV disease progression HIV-positive patients coinfected with HCV up to 80% more likely to die even with HIV treatment My battle against hepatitis C - Daily Express 16th August My battle against hepatitis C - Daily Express 16th August Science journal Nature publishes on-line supplement on hepatitis C Science journal Nature publishes on-line supplement on hepatitis C Scotland - Needle exchange at police stations Story from the East Anglian Daily Times - Monday 1st August The Hepatitis C Trust Shocked At Ignorance Of Hep C Slander In The Film BEWITCHED The Hepatitis C Trust Shocked At Ignorance Of Hep C Slander In The Film BEWITCHED July Brighton- next venue for Face It awareness campaign photography exhibition FaCe It awareness campaign-photography exhibition in Nottingham July 1st - Hepatitis C Trust Helpline celebrates its 1st anniversary Norwich PCT unable to give firm commitment to Hepatitis C Action Plan Nottingham's Market Square to host Department of Health awareness campaign FaCe It exhibition Questions about the Skipton Fund asked in parliament on 20th July 2005 Scotland - Families affected by hepatitis C to lose compensation Sun 7/7/05 '500,000 Brits don't know they have our killer disease' The Hepatitis C Trust wins award for Patient Association of the year 2005 June Aim to help hepatitis C lose stigma BBC News Online - 'Test tube' hope for hep c drug Researchers at The Rockefeller University create infectious hepatitis C virus in a test tube Scientists discover how virus evades immune system Scotland - More to get hepatitis C payouts Study shows 12 weeks of treatment as effective as 24 weeks in certain hepatitis C patients The death of a soldier May Combination Treatment for children shows promise April Experimental form of interferon-alpha meets primary goal in mid-stage trial Food Supplements Directive deemed invalid HCV infection may be concealed initially New data calls into question the 'watch and wait' treatment strategy for hepatitis C Selected Highlights from the 40th EASL Conference Survey reveals huge numbers with Liver Disease and Inequalities in access to care and treatment across European Union Wrong, Pamela, there is a cure - Daily Telegraph 28.4.05 March Ex-Beach Boy Urges Awareness over Hepatitis C Full page interview with Beach Boy, David Marks, The Times 16.3.05 Hepatitis C action 'inadequate' BBC News Online 22.03.2005 Hepatitis C and health-related quality of life Scientists replicate hepatitis C virus in laboratory 'The Hepatitis C Scandal' Report from the APPGH launched 22.03.2005 February Combination therapy approved for the treatment of HCV/HIV co-infection in Europe Conferences - 2005 Genotype 1 - High dose therapy trial achieves 90% success rate. Health Protection Agency - 'Look-back' Health Protection Agency - Needlestick injuries in healthcare workers still occurring Hidden Epidemic of Hepatitis C a top story in The Independent 23.02.05 How Hepatitis C Short-Circuits the Immune System Information processing deficits in patients with chronic hepatitis c Methods Viruses use to Sidestep Immune System Scientist may have found why hepatitis C triggers chronic infection. January Documents released under the Freedom of Information Act show NHS knew blood for transfusions was contaminated with Hepatitis. Hepatitis C Treatment - An American study suggests depression may affect outcome. Irish Health Department calls for publication of report for Blood Transfusion Service 2004 December Department of Health launches Hepatitis C Awareness Campaign November Helpline Poster Wins Award October +ve Launch New Website for International Hepatitis C Awareness Day New Web Resource Providing Links to Hepatitis Patient Groups Internationally August Research Shows First Evidence That Vaccine Possible for Multiple Strains Of Hepatitis C Researchers Identify Breakthrough in Hepatitis C Virus Infection July Latest long-term study results of sexual transmission risk June Skipton fund announcement January NICE's new guidelines on Pegylated Interferon launched on 28th January 2004 Media centre Press releases The Trust in the news Resources Leaflets Reports Posters Newsletters Podcasts - Audio & Video Glossary	The Trust About us About us The team The CEO Our Work Raising awareness Improving information Providing support Increasing testing Outreach and testing van Peer to Peer Education Pharmacy testing Training Representation Policy and Parliamentary Top policy goals All Party Parliamentary Hepatology Group HCVAction International Past events and campaigns South Asian awareness event July 2011 South Asian event photos Medicine and Me Lesley Jenkins Video Medicine and Me videos What Not to Share Transmission WNTS Gallery WNTS Videos Donate Contact us Contact Us How to find us Complaints Enquiries about our website Training Training from the Hepatitis C Trust Trust Updates

Hepatitis Info

Treatment

Living with

Support

News & Resources

Get Involved

About us

[Sign In] [Sign Up]